110 related articles for article (PubMed ID: 3145431)
1. Pharmacotherapy of concomitant psychiatric disorders in adolescent substance abusers.
Geller B
NIDA Res Monogr; 1988; 77():94-112. PubMed ID: 3145431
[No Abstract] [Full Text] [Related]
2. Preliminary report on psychiatric comorbidity in adolescent substance abusers.
Monopolis SJ; Brooner RK; Jadwisiak RM; Marsh E; Schmidt CW
NIDA Res Monogr; 1990; 105():293-4. PubMed ID: 1876016
[No Abstract] [Full Text] [Related]
3. Impact of psychiatric comorbidity on treatment of adolescent drug abusers.
Rowe CL; Liddle HA; Greenbaum PE; Henderson CE
J Subst Abuse Treat; 2004 Mar; 26(2):129-40. PubMed ID: 15050090
[TBL] [Abstract][Full Text] [Related]
4. Long-term drug use in psychiatric disorders in children. Facts, controversies and the future.
Werry JS
Acta Paedopsychiatr; 1993; 56(2):113-8. PubMed ID: 7907832
[TBL] [Abstract][Full Text] [Related]
5. [Use of new drug treatments in child psychiatry (long-acting neuroleptics, antidepressive agents and lithium)].
Dugas M; Velin J; Guériot C; Frohwirth C
Cah Med; 1973 Sep; 14(9):711-6. PubMed ID: 4779496
[No Abstract] [Full Text] [Related]
6. Psychiatric disorders in treatment-entering cocaine abusers.
Rounsaville B; Carroll K
NIDA Res Monogr; 1991; 110():227-51. PubMed ID: 1944500
[No Abstract] [Full Text] [Related]
7. The symptomatic and prognostic implications of psychiatric diagnoses in treated substance abusers.
Kosten T
NIDA Res Monogr; 1988; 81():416-21. PubMed ID: 3136380
[No Abstract] [Full Text] [Related]
8. [Drugs and internal pollution].
Villeneuve A
Vie Med Can Fr; 1972 Feb; 1(2):195-8. PubMed ID: 4637398
[No Abstract] [Full Text] [Related]
9. [Psychotropic drug therapy and pharmaceutical industry].
Modestin J
Arzneimittelforschung; 1970 Jul; 20(7):877-9. PubMed ID: 5536047
[No Abstract] [Full Text] [Related]
10. The antidepressant quandary--considering suicide risk when treating adolescent depression.
Simon GE
N Engl J Med; 2006 Dec; 355(26):2722-3. PubMed ID: 17192536
[No Abstract] [Full Text] [Related]
11. Psychoactive-drug use among adolescents with psychiatric disorders.
Groves JB; Batey SR; Wright HH
Am J Hosp Pharm; 1986 Jul; 43(7):1714-8. PubMed ID: 3752107
[TBL] [Abstract][Full Text] [Related]
12. The impact of pharmacotherapy on psychiatric practice and research.
Flach FF
Ment Hyg; 1966 Oct; 50(4):570-3. PubMed ID: 5969628
[No Abstract] [Full Text] [Related]
13. [Open study of minaprine in a child psychiatry population (author's transl)].
de Villard R; Dallery J; Maillet J; Soulier C
Neuropsychiatr Enfance Adolesc; 1981; 29(4-5):255-8. PubMed ID: 7335167
[No Abstract] [Full Text] [Related]
14. The impact of modern pharmacotherapy on the prognosis of psychiatric patients.
Lehmann HE
Trans Assoc Life Insur Med Dir Am; 1970; 53():31-47. PubMed ID: 5465245
[No Abstract] [Full Text] [Related]
15. Prescription of psychotropic drugs by general practitioners. 1. General.
Rowe IL
Med J Aust; 1973 Mar; 1(12):589-93. PubMed ID: 4700545
[No Abstract] [Full Text] [Related]
16. Pharmacotherapy for adolescents with psychoactive substance use disorders.
Kaminer Y
NIDA Res Monogr; 1995; 156():291-324. PubMed ID: 8594475
[No Abstract] [Full Text] [Related]
17. Comfort without drugs.
Br Med J; 1973 Aug; 3(5876):367. PubMed ID: 4730183
[No Abstract] [Full Text] [Related]
18. [Usefulness and hazards of psychopharmacological agents].
Marino A
Clin Ter; 1974 Oct; 71(1):3-12. PubMed ID: 4426175
[No Abstract] [Full Text] [Related]
19. Smoking cessation efforts among substance abusers with and without psychiatric comorbidity.
Unrod M; Cook T; Myers MG; Brown SA
Addict Behav; 2004 Jul; 29(5):1009-13. PubMed ID: 15219350
[TBL] [Abstract][Full Text] [Related]
20. Orofacial symptoms in psychiatric disease.
Redpath TH
Dent Pract Dent Rec; 1971 May; 21(9):301-6. PubMed ID: 5281132
[No Abstract] [Full Text] [Related]
[Next] [New Search]
